Recently added articles from Pharmaceutical Executive:
Cutter's Way
Aug 01, 2008; Clinton, Patrick ... This year the Supreme Court has given itself three opportunities to rule on the question of whether FDA decisions trump the ability of consumers to sue pharma companies in state courts. The score so far: one minor loss for pharma and one pretty big win for medical devices, with a big case yet to ...
Leading Indicators
Aug 01, 2008; Koroneos, George ... People + events + ideas that are shaping pharma's future Roche has been a very busy pharma, snagging two smaller firms and putting in a bid to purchase the remaining shares of Genentech that it doesn't already own Roche announced that had offered $43.7 billion to fully acquire ...
On The Web
Aug 01, 2008; Anonymous ... LISTEN UP! On Sept. 11, Pharm Exec will be hosting a live Webcast "Maximizing Efficiencies in the Pharmaceutical Laboratory, Part 1: Better Asset Utilization of Existing MS Instrumentation". Also check out the interactive video Webcasts from Pharmaceutical Executive: A Better Way to Conduct ...
Medicare Widens Options for Off-Label Drug Use
Aug 01, 2008; Wechsler, Jill ... POLICY Policy change improves treatment reimbursment Following a change in ledicare policy, insurers and formulary committees have a wider pool of resources from which to base their coverage decisions regarding off-label uses of drugs. The policy applies specifically to off-label ...
UK Chooses GSK Vaccine
Aug 01, 2008; Houlton, Sarah ... VACCINES Ceravix selected for British HPV immunization program With a possibility of being delayed yet again in the US, GlaxoSmithKline's Cervarix has received a major boost in Europe. The human papillomavirus vaccine, designed to prevent cervical cancer, has been selected by the ...
Marketers Limit Largesse to Doctors
Aug 01, 2008; Wechsler, Jill ... PROMOTION PhRMA code aims to head off stiffer curbs on marketing programs Pharmaceutical marketing has been under attack in Washington and state legislatures, and industry is trying to regain credibility by reining in practices that appear excessive. Marketers have agreed to ban ...
Daiichi Sankyo Snags Ranbaxy for $4.6 Billion
Aug 01, 2008; Houlton, Sarah ... DEALS Japanese pharma picks up biggest Indian firm to bolster business India's largest pharma company, Ranbaxy, is selling a controlling stake in its business to Daiichi Sankyo of Japan. Worth up to $4.6 billion, the sale will leave the Indian company with its own name and ...
"Approvable" No More
Aug 01, 2008; Wechsler, Jill ... REGULATORY FDA attempts to clarify its rulings by spelling out the difference between a good drug and a bad drug A new policy from FDA aims to clear up widespread confusion and uncertainty related to the "approvable" and "non-approvable" letters sent to pharma companies when the ...
Deferred Care
Aug 01, 2008; Anonymous ... FDA Swing states doing without NPR, Kaiser Family Foundation, and the Harvard School of Public Health recently examined the financial problems related to healthcare affecting people in Ohio and Florida-two Presidential swing states. A quarter of Ohioans and 28 percent of ...
Doctor No-See
Aug 01, 2008; Anonymous ... SALES FORCE Who wants to talk to sales reps SK&A Information Services recently wrapped up its study of how much access pharmaceutical sales reps have to physicians, and the survey says that neuroradiology specialists, with a 92.23 percent rejection rate, are the least likely ...
Jumping the Gun
Aug 01, 2008; Houlton, Sarah ... New British price regulations to come online a year early, but increased support for innovation may provide a silver lining for pharma For more than half a century, drug rices in the United Kingdom have een set by the Pharmaceutical Price Regulation Scheme (PPRS), a "cost plus" profit ...
Can Sentinel Save Drug Development?
Aug 01, 2008; Wechsler, Jill ... Broader access to health system data promises to revolutionize drug safety monitoring-and could expedite approval of new drugs Presently, the only real postmarket surveillance in the pharmaceutical industry comes from passive, generally unreliable adverse event reports by doctors and ...
Searching for Meaning
Aug 01, 2008; Aker, J Brooke ... In an expanding universe of unstructured information, the keywords for value are "semantic intelligence" The amount of "unstructured information"-data not easily read by a computer-that pharmaceutical companies produce staggers the mind. This information typically appears in the form of ...
inside the doughnut hole
Aug 01, 2008; Tenaglia, Mason; Mitchell, Lauri; Mandia, Keith ... Demystifying the Medicare Part D coverage gap: Not as many patients are exposed to it as you'd think, and the real effects are on a group of patients who don't fall in IT'S MIDSUMMER, AND across the country pharma sales managers are participating in what's become an annual ritual ....
HARD OF (AD)HERING
Aug 01, 2008; Koroneos, George ... Pharma companies are looking for new ways to get patients to stay on their meds. The consensus is that if enough adherence tools are thrown at the wall, some will have to stick. But is that the answer? When your biggest products are going off patent, your biggest customers are pushing ...
Harbingers OF change
Aug 01, 2008; Anonymous ... 8 Pharma Trends in the Making For now, the future seems to recede ever further in the media onslaught of the endless presidential campaign. But come November 5, when life as we once knew it resumes, the drug industry will have not only a new administration to do business with but a bunch ...
Do something!
Aug 01, 2008; Schiemann, William A ... BOOSTING PHARMA SALES REQUIRES A SOUND STRATEGY, FOCUS ON PERFORMANCE DRIVERS, AND PROACTIVE MANAGEMENT OF TOP PERSONNEL "DON'T JUST STAND THERE,DO SOMETHING," has long been an axiom of American business, especially within the vitally active sales functions. Pharmaceutical companies have ...
Greece's Pharmaceuticals: Classical Thinking For A Modern Industry
Aug 01, 2008; Anonymous ... Greece's contributions to health are worldrenowned, whether through its Mediterranean diet and climate, or as the genesis of Western philosophy and mathematics. Less well-known are its modern-day activities in the pharmaceutical industry, where the blossoming market is distinctive for its ...
Next Generation Event Consolidation
Aug 01, 2008; Krugman, Carol ... A comprehensive strategy enabled by new tools and processes will help pharma companies make the quantum leap from chaos to compliance A few years ago, when you saw a pharmaceutical company consolidating its overall event and marketing spend, you could be pretty sure that the goal was to ...
Spanning the Treatment Gap
Aug 01, 2008; Lorenzi, Gayle; Schreiner, Barbara; Black, Jimmy ... Amylin tried a new approach to helping healthcare pros plug into new diabetes therapies While education is a cornerstone of any clinical practice, sales teams often fall short of informing doctors and other healthcare professionals how to successfully integrate new therapies into patient ...